AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 30100336
Drug: Intravenous dexketoprofen
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexketoprofen 50 mg
Trial: 21114791
Drug: HMPL-004 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMPL-004 1200 mg/day
Trial: 21114791
Drug: Mesalazine 4500
RxNorm normalized name: Mesalamine
DrugBank: Mesalazine (DB00244)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mesalazine 4500 mg/day
Trial: 22092168
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) infusion
Trial: 18049171
Drug: Midazolam (2.87±0.67
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (2.87±0.67 mg)
Trial: 18049171
Drug: Midazolam (1.82±0.71
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (1.82±0.71 mg) with Meperidine (42.81±14.61 mg)
Trial: 7527170
Drug: Single preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single preoperative oral dose of 400 mg lomefloxacin followed by 400 mg daily for 3 days
Trial: 25556817
Drug: Glucose-only (G)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose-only (G)
Trial: 9352870
Drug: Interferon alfa
RxNorm normalized name: Interferon alfa
DrugBank: Interferon alfa (DB05258)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa (IFN‐alpha) therapy
Trial: 8408979
Drug: Evening light
RxNorm normalized name: Evenity
DrugBank: Romosozumab (DB11866)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Evening light treatment (EL)
Trial: 8408979
Drug: Both ML
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both ML and EL
Trial: 3955198
Drug: 160 mg
RxNorm normalized name: nadolol 160 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 mg micronized megestrol acetate tablet
Trial: 3955198
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg megestrol acetate tablet (Megace)
Trial: 19910173
Drug: Catechin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Catechin (500 microg) with antitubercular treatment (ATT)
Trial: 18626312
Drug: MS-275 3
RxNorm normalized name: morphine
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MS-275 3 mg biweekly (days 1+15, arm A)
Trial: 7751822
Drug: lovastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin (40 mg b.i.d.) + low cholesterol diet (mean 246 mg/day)
Trial: 7751822
Drug: lovastatin +
RxNorm normalized name: Lovastatin
DrugBank: Lovastatin (DB00227)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: lovastatin + high cholesterol diet (mean 1071 mg/day)
Trial: 27025903
Drug: Gemcitabine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine plus S-1 therapy
Trial: 18930988
Drug: Initial treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Initial treatment with methotrexate (MTX) plus infliximab (IFX)
Trial: 18930988
Drug: Delayed treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed treatment with methotrexate (MTX) plus infliximab (IFX)
Trial: 17444858
Drug: fermented papaya
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fermented papaya preparation (FPP) 9 g/day
Trial: 10221185
Drug: Oral Diantalvic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Diantalvic (paracetamol-noramidopyrine) as rescue analgesic
Trial: 6812750
Drug: Ketanserin 10
RxNorm normalized name: ketanserin
DrugBank: Ketanserin (DB12465)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin 10 mg intravenously
Trial: 30348514
Drug: ALKS 3831
RxNorm normalized name: ALKS 29
DrugBank: ALKS 29 (DB05723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALKS 3831 10/10 (10‐mg olanzapine/10‐mg samidorphan)
Trial: 30348514
Drug: ALKS 3831
RxNorm normalized name: ALKS 29
DrugBank: ALKS 29 (DB05723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALKS 3831 20/10 (20‐mg olanzapine/10‐mg samidorphan)
Trial: 20424282
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy; specific dosage and duration not mentioned.
Trial: 20424282
Drug: No treatment;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment; control group not explicitly mentioned.
Trial: 18791892
Drug: Traditional weekly
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Traditional weekly sessions (TWS)
Trial: 8807168
Drug: Propofol (RivP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (RivP 18, 15, 12, 9 and 0 mg.kg‐1.hr‐1)
Trial: 6368345
Drug: Propranolol (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (16 mg)
Trial: 6368345
Drug: Penbutolol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Penbutolol (4 mg)
Trial: 31272502
Drug: Nitrous oxide/oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrous oxide/oxygen mixture (1:1) plus conventional treatment (no analgesics)
Trial: 31272502
Drug: Oxygen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen plus conventional treatment (no analgesics)
Trial: 22863266
Drug: albIFN 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albIFN 1200 μg q4wk
Trial: 22863266
Drug: albIFN 1500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: albIFN 1500 μg q4wk
Trial: 8682015
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg alteplase (n = 246)
Trial: 29741634
Drug: peginterferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: peginterferon alfa‐2a in combination with lamivudine
Trial: 16323175
Drug: Voice therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Voice therapy
Trial: 21080348
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) cyclophosphamide (CYC)
Trial: 12236626
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg, days 1-7; 40 mg, days 8-14)
Trial: 7478022
Drug: Direct intraventricular
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct intraventricular infusion of urokinase
Trial: 18304172
Drug: Tacrolimus ointment
RxNorm normalized name: Tacrolimus Ointment
DrugBank: Tacrolimus (DB00864)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tacrolimus ointment 0.03% vs 0.1%
Trial: 12874940
Drug: Exercise program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise program (1 hour, twice a week)
Trial: 8739172
Drug: Guided tissue
RxNorm normalized name: tissue respiratory factor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided tissue regeneration (GTR) with non-resorbable ePTFE membranes and systemic antimicrobial therapy (ornidazole)
Trial: 8739172
Drug: No membrane
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No membrane and systemic antimicrobial therapy (ornidazole)
Trial: 24847853
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet (0.6 g protein · kg body weight(‐1) · d(‐1), 7% of energy from protein)
Trial: 22863669
Drug: Memantine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Memantine (10 mg) in subjects with mild renal impairment (50 to ≤ 80 mL/min)
Trial: 2095605
Drug: Ambroxol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol (1 g/day for 4 days before and 4 days after surgery)
Trial: 31734103
Drug: Cenobamate 100
RxNorm normalized name: cenobamate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenobamate 100 mg
Trial: 31292226
Drug: Cenobamate 250
RxNorm normalized name: cenobamate 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenobamate 250 mg
Trial: 31734103
Drug: Cenobamate 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenobamate 400 mg
Trial: 31292226
Drug: Cenobamate (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cenobamate (250 mg and 400 mg doses)
Trial: 23564348
Drug: 300,000 IU
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300,000 IU (7,500 μg) i.m. cholecalciferol
Trial: 21214633
Drug: Topical combination
RxNorm normalized name: soap TOPICAL COMBINATION PACKAGE (EA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical combination of levomenol and heparin (Group A)
Trial: 16254422
Drug: Heparin alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin alone (Group C)
Trial: 21214633
Drug: Cream base
RxNorm normalized name: Cream Base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream base with no active substances (Group D)
Trial: 17954367
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with olmesartan 10 mg/day and temocapril 2 mg/day
Trial: 17954367
Drug: Temocapril 2
RxNorm normalized name: temocapril
DrugBank: Temocapril (DB08836)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temocapril 2 mg/day
Trial: 11745583
Drug: Directed problem-solving
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directed problem-solving treatment program (control)
Trial: 2520494
Drug: PGE1 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PGE1 (200 micrograms 4 times daily)
Trial: 12457302
Drug: Acetylsalicylic acid
RxNorm normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acetylsalicylic acid (ASA) 100 mg, 300 mg, or 500 mg administered as a single dose or daily for 10 consecutive days
Trial: 30788810
Drug: GIK (glucose-insulin-potassium)
RxNorm normalized name: glucose / potassium chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK (glucose-insulin-potassium)
Trial: 7030855
Drug: GIK +
RxNorm normalized name: Glucose-Insulin-Potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK + Verapamil (50 mg continuous drip)
Trial: 7030855
Drug: GIK +
RxNorm normalized name: Glucose-Insulin-Potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK + Digoxin (0.25 mg b.i.d.)
Trial: 26884592
Drug: 50.4 Gy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50.4 Gy in 28 fractions combined with two 5‐day cycles of bolus 5‐Fu 325 mg/m(2)/day and leucovorin 20 mg/m(2)/day during the first and fifth week of irradiation along with five infusions of oxaliplatin 50 mg/m(2) once weekly (group B)
Trial: 20860447
Drug: Intraoperative wound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative wound infiltration with 150 mL ropivacaine (2 mg/mL), 1 mL ketorolac (30 mg/mL), and 0.5 mL epinephrine (1 mg/mL) combined with intraarticular infusion (4 mL/h) of 190 mL ropivacaine (2 mg/mL) plus 2 mL ketorolac (30 mg/mL) (group A)
Trial: 20860447
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion (4 mL/h) of 192 mL ropivacaine (2 mg/mL) combined with 6 intravenous administrations of 0.5 mL ketorolac (30 mg/mL) for 48 h postoperatively (group E)
Trial: 10529932
Drug: 2.0% dorzolamide/0.5%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0% dorzolamide/0.5% timolol fixed combination (COSOPT)
Trial: 9700984
Drug: Ticlopidine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine (250 mg/day)
Trial: 21093861
Drug: Elevated serum
RxNorm normalized name: Serum, horse
DrugBank: Serum, horse (DB14613)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated serum PAPP‐A (≥4mIU/L)
Trial: 21934637
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg sildenafil
Trial: 10082152
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg oral glibenclamide
Trial: 1778860
Drug: Erythromycin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (200 mg daily for neonates, 1000 mg daily for adults)
Trial: 1778860
Drug: Roxithromycin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin (50 mg daily for neonates, 300 mg daily for adults)
Trial: 29095417
Drug: Web-based multimedia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Web-based multimedia patient engagement program (Emmi Solutions)
Trial: 8208677
Drug: GenHevac B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GenHevac B vaccine (20 micrograms)
Trial: 8208677
Drug: Hevac B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hevac B vaccine (5 micrograms)
Trial: 4875006
Drug: Neomycin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neomycin (2 g orally daily)
Trial: 30698725
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein (MILK) 20 g
Trial: 30698725
Drug: Micellar casein
RxNorm normalized name: Douxo Micellar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micellar casein protein (CASEIN) 20 g
Trial: 29349988
Drug: Patient-Controlled Intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-Controlled Intravenous Analgesia (PCIA) with controlled instillation of sufentanil
Trial: 29349988
Drug: Multimodal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal analgesia including continuous femoral nerve block, local injection of knee joint, and buprenorphine patches
Trial: 26479485
Drug: Manual-based multimodal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual-based multimodal treatment (MT)
Trial: 9221571
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (group A)
Trial: 9221571
Drug: Human insulin
RxNorm normalized name: Human insulin
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human insulin (group B)
Trial: 29723235
Drug: Anma therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anma therapy (AMT)
Trial: 29723235
Drug: No Anma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Anma therapy (no-AMT)
Trial: 21786434
Drug: Cilostazol pretreatment
RxNorm normalized name: Cilostazol
DrugBank: Cilostazol (DB01166)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cilostazol pretreatment (200 mg/day for 7 days)
Trial: 19368659
Drug: MRI after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI after ingestion of 200 mL meal
Trial: 19368659
Drug: MRI after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MRI after ingestion of 800 mL meal
Trial: 19368659
Drug: Breath test
RxNorm normalized name: MERETEK UBT BREATH TEST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breath test (BT) after ingestion of 200 mL meal
Trial: 19368659
Drug: Breath test
RxNorm normalized name: MERETEK UBT BREATH TEST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breath test (BT) after ingestion of 800 mL meal
Trial: 17077429
Drug: Individual music
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual music therapy plus standard care
Trial: 9065193
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml of 0.4% chlorhexidine
Trial: 9065193
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml of sterile water (placebo)
Trial: 29277353
Drug: PHiD-CV 4-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHiD-CV 4-dose vial (with preservative)
Trial: 27681760
Drug: Postmastectomy radiation
RxNorm normalized name: allantoin
DrugBank: Allantoin (DB11100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postmastectomy radiation therapy (PMRT)
Trial: 18356694
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus tirofiban infusion administered together during inclusion (n = 10)
Trial: 18356694
Drug: Clopidogrel administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel administered at inclusion and followed 2 hours after by tirofiban (n = 7)
Trial: 18356694
Drug: Clopidogrel plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel plus tirofiban infusion (group A)
Trial: 18356694
Drug: Clopidogrel administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel administered at inclusion and followed 2 hours after by tirofiban (group B)
Trial: 15978308
Drug: Control (treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (treatment A): intact tablet with 120 mL water
Trial: 15978308
Drug: Treatment B:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment B: crushed tablet mixed with 4 oz applesauce
Trial: 15978308
Drug: Treatment C:
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment C: crushed tablet mixed with 120 mL of a common ENF
Trial: 14613023
Drug: Anastrozole (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole (1 mg once daily)
Trial: 14613023
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Anastrozole plus Tamoxifen
Trial: 10356087
Drug: 500-microgram phylloquinone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500-microgram phylloquinone tablet
Trial: 10356087
Drug: 150 g
RxNorm normalized name: TOCOPHEROL 2 g in 150 g TOPICAL OIL [TUREMRIC]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 g of raw spinach
Trial: 10356087
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g of spinach
Trial: 8403654
Drug: Debridement and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debridement and intravenous antibiotics for four weeks
Trial: 8403654
Drug: Debridement, gentamicin-polymethylmethacrylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debridement, gentamicin-polymethylmethacrylate (Septopal) beads, and perioperative broad-spectrum parenteral antibiotics
Trial: 24607303
Drug: Brazil nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazil nuts (20 g)
Trial: 24607303
Drug: Brazil nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazil nuts (50 g)
Trial: 24607303
Drug: Brazil nuts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brazil nuts (5 g)
Trial: 16914701
Drug: Daptomycin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daptomycin (6 mg/kg daily)
Trial: 6396248
Drug: 10% crotamiton
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% crotamiton lotion
Trial: 26685701
Drug: Vilazodone (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilazodone (up to 40 mg/day)
Trial: 24628408
Drug: Face Mask
RxNorm normalized name: CVS Face Masks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face Mask (FM) treatment
Trial: 24628408
Drug: Face Mask
RxNorm normalized name: CVS Face Masks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face Mask (FM) treatment with Rapid Maxillary Expansion (RME)
Trial: 21179724
Drug: Chinese drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese drugs for benefiting‐qi, activating‐blood, dissolving phlegm and removing‐toxin (CDs) combined with basic therapy
Trial: 24261227
Drug: Basic therapy
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic therapy only (Control)
Trial: 15620437
Drug: Orlistat 360
RxNorm normalized name: Orlistat
DrugBank: Orlistat (DB01083)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Orlistat 360 mg/day for one year
Trial: 10347106
Drug: Ursodeoxycholic acid
RxNorm normalized name: Ursodeoxycholic acid
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ursodeoxycholic acid (UDCA) treatment
Trial: 2297261
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue spray (2 ml applied before thoracotomy closure)
Trial: 832923
Drug: Hypnotic subjects
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hypnotic subjects (Ss)
Trial: 832923
Drug: Hypnotic Ss
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnotic Ss responding to difficult task aspects
Trial: 31488259
Drug: Steroids (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroids (first line treatment)
Trial: 31488259
Drug: Rituximab (monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (monotherapy or in association with steroids)
Trial: 31488259
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of steroids with rituximab
Trial: 25730283
Drug: Epinephrine injection
RxNorm normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine injection plus soft coagulation using hemostatic forceps (HFSC)
Trial: 25730283
Drug: Epinephrine injection
RxNorm normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine injection plus argon plasma coagulation (APC)
Trial: 23523332
Drug: Injections during
RxNorm normalized name: Pro-C-Dure 6 Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injections during labor
Trial: 17084960
Drug: alpha‐blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha‐blocker
Trial: 17084960
Drug: triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triple therapy (alpha‐blocker, anti‐inflammatory, and muscle relaxant)
Trial: 12118903
Drug: Darusentan 10
RxNorm normalized name: Darusentan
DrugBank: Darusentan (DB04883)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Darusentan 10 mg